Evaluation of Cardiovascular Health Outcomes Among Survivors (ECHOS)
November 25, 2013 updated by: St. Jude Children's Research Hospital
This study will test a 2-tiered tailored intervention and evaluation of cardiovascular health outcomes among survivors designed to inform childhood cancer survivors about their individual cardiac risk and follow-up recommendations and to provide motivational support for cardiovascular (CV) screening.
This study will test if the addition of telephone motivational interviewing, tailored to behavioral constructs, is superior to the current standard of care in increasing survivors' CV screening.
Study Overview
Status
Completed
Conditions
Detailed Description
- This study will test the hypothesis that at 1 year post-intervention, a significantly greater proportion of the advanced-practice nurse (APN) phone counseling group will have undergone cardiovascular screening, as compared to the standard care group. Cardiovascular (CV) screening will be defined, based on established CV screening recommendations, as completion of an imaging evaluation of left ventricular systolic function (i.e., echocardiogram, multiple uptake gated acquisition scan, or cardiac magnetic resonance imaging).
This study will measure changes induced by the intervention in survivors' knowledge, motivation, fear, beliefs, affect, readiness for medical follow-up, and self-efficacy and these changes' potential mediating effects on CV screening.
- This study will provide a cost analysis of the ECHOS intervention in terms of the cost of left ventricular systolic function imaging per additional survivor screened, an estimate of the cost of standard care per survivor screened, and the cost of screening and follow-up per survivor screened.
Study Type
Interventional
Enrollment (Actual)
509
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Tennessee
-
Memphis, Tennessee, United States, 38105
- St . Jude Children's Research Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
25 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Childhood Cancer Survivor Study (CCSS) cohort participants
- Age 25 years or older
- No CV screening in previous 5 years
- Received anthracycline chemotherapy and/or irradiation of the chest
- Previous history of successful independent (non-surrogate) response to CCSS surveys (reading level for non-medical items is 4th-6th grade Flesch-Kincaid level).
Exclusion Criteria:
- Being followed at an institution actively recruiting adults to a long-term follow-up program (ascertained in CCSS follow-up database)
- Inability or unwillingness of research participant to give written informed consent.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Control Arm
Control arm will receive standard care for risk of cardiac sequelae - a mailed, tailored (neither generic nor targeted) print summary of individualized information about the survivor's treatment, late effects risks, and recommended follow-up and lifestyle modifications.
|
A mailed individualized cancer treatment summary with recommendations for CV follow-up and lifestyle modification (standard care).
Other Names:
Standard care plus motivational, autonomy-supportive APN counseling (2 phone sessions) that targets two categories of behavioral constructs likely to influence screening.
Other Names:
|
|
Other: Test Arm
Test arm will receive standard care plus motivational, autonomy-supportive APN counseling (2 phone sessions) that targets two categories of behavioral constructs likely to influence screening.
|
A mailed individualized cancer treatment summary with recommendations for CV follow-up and lifestyle modification (standard care).
Other Names:
Standard care plus motivational, autonomy-supportive APN counseling (2 phone sessions) that targets two categories of behavioral constructs likely to influence screening.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
This study will test the hypothesis that at 1 year post-intervention, a significantly greater proportion of the APN phone counseling group will have undergone cardiovascular screening, as compared to the standard care group
Time Frame: 2.5 years
|
2.5 years
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in knowledge
Time Frame: Baseline and 2.5 years post intervention
|
Baseline and 2.5 years post intervention
|
|
Change in motivation
Time Frame: Baseline and 2.5 years post intervention
|
Baseline and 2.5 years post intervention
|
|
Change in fear
Time Frame: Baseline and 2.5 years post intervention
|
Baseline and 2.5 years post intervention
|
|
Change in beliefs
Time Frame: Baseline and 2.5 years post intervention
|
Baseline and 2.5 years post intervention
|
|
Change in affect
Time Frame: Baseline and 2.5 years post intervention
|
Baseline and 2.5 years post intervention
|
|
Change in readiness for medical follow-up
Time Frame: Baseline and 2.5 years post intervention
|
Baseline and 2.5 years post intervention
|
|
Change in self-efficacy
Time Frame: Baseline and 2.5 years post intervention
|
Baseline and 2.5 years post intervention
|
|
Estimated average cost of intervention per participant
Time Frame: 2.5 years
|
2.5 years
|
|
Estimated average cost of standard care per participant in the Control Arm
Time Frame: 2.5 years
|
2.5 years
|
|
Estimated average cost of cardiovascular screening per participant in the Test Arm
Time Frame: 2.5 years
|
2.5 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Melissa Hudson, MD, St. Jude Children's Research Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2010
Primary Completion (Actual)
July 1, 2013
Study Completion (Actual)
July 1, 2013
Study Registration Dates
First Submitted
October 27, 2009
First Submitted That Met QC Criteria
October 28, 2009
First Posted (Estimate)
October 29, 2009
Study Record Updates
Last Update Posted (Estimate)
November 26, 2013
Last Update Submitted That Met QC Criteria
November 25, 2013
Last Verified
November 1, 2013
More Information
Terms related to this study
Other Study ID Numbers
- ECHOS
- R01NR011322 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.